Clinical characteristics (n = 225)
| Characteristic . | No.evaluable . | Median (range) . | Value . | No.patients (%) . |
|---|---|---|---|---|
| Patient age (years) | 225 | 58 (21-87) | <60 | 119 (53) |
| ≥60 | 106 (47) | |||
| Rai stage | 181 | 0-II | 122 (67) | |
| III-IV | 59 (33) | |||
| Binet stage | 178 | A | 82 (46) | |
| B | 50 (28) | |||
| C | 46 (26) | |||
| ≥40 | 109 (50) | |||
| β2-microglobulin (mg/dL) | 175 | 2.8 (1.1-36.6) | <2 | 35 (20) |
| ≥2 | 140 (80) |
| Characteristic . | No.evaluable . | Median (range) . | Value . | No.patients (%) . |
|---|---|---|---|---|
| Patient age (years) | 225 | 58 (21-87) | <60 | 119 (53) |
| ≥60 | 106 (47) | |||
| Rai stage | 181 | 0-II | 122 (67) | |
| III-IV | 59 (33) | |||
| Binet stage | 178 | A | 82 (46) | |
| B | 50 (28) | |||
| C | 46 (26) | |||
| ≥40 | 109 (50) | |||
| β2-microglobulin (mg/dL) | 175 | 2.8 (1.1-36.6) | <2 | 35 (20) |
| ≥2 | 140 (80) |